Latest Breaking News On - Clerval - Page 1 : comparemela.com
Paris, France, March 27, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces that its management will be attending the following upcoming investor and industry conferences: Cell & Gene Meeting on the Med – April 9-11 ; Rome, ItalyCompany Presentation by CEO Rodolphe Clerval on April 10 at 13.45 CET LSX World Congress – April 29-30 ; London, UKCEO Rodolphe Clerval attending and available for investor meetings BioEquity Europe –
United-statesClervalFranche-comtérFranceSpainUnited-kingdomItalyLondonCity-ofRomeLazioParisParis, France, September 28, 2023 – Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies for CNS (Central Nervous System) and eye diseases, announces that CEO Rodolphe Clerval will be presenting to investors and peers at the following Investor and Industry conferences: Chardan’s 7th Annual Genetic Medicines Conference – October 2-3 New York City, NY, USAPresenting on October 2 at 11:30 EDT Cell & Gene Meeting on the Mesa – October 10-12 Carlsbad,
NetherlandsUnited-statesParisFrance-generalFranceTorremolinosAndalucíspSpainBelgiumNew-yorkAmsterdamNoord-holland